Overview

This randomized controlled trial aims to compare the efficacy of Eye Movement Desensitization and Reprocessing (EMDR) therapy versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the treatment of Post-Traumatic Stress Disorder (PTSD). Adult patients diagnosed with PTSD will be randomly assigned to receive either EMDR therapy or SSRIs for a period of six weeks. The primary outcome is the rate of remission as measured by validated PTSD symptom severity scales at Week 6. Secondary outcomes include changes in functional impairment and patient-reported quality of life. The study seeks to determine whether EMDR therapy is a non-pharmacological alternative to SSRIs for achieving symptom remission in PTSD.

Eligibility

Inclusion Criteria:

Age 18-60 years

Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD)

Duration of illness ≥ 6 months

Able to provide informed consent

Exclusion Criteria:

Current substance abuse or dependence

History of psychotic disorder or bipolar disorder

Active suicidal ideation

Concurrent psychotherapy or psychiatric medication (except study-assigned SSRI)